Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Industry
Pharmaceutical Preparations
Location
455 Mission Bay Boulevard South, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INHALE THERAPEUTIC SYSTEMS INC (to 1/10/2003), INHALE THERAPEUTIC SYSTEMS (to 5/14/1998)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 722 % -0.57%
Quick Ratio 33 % +38.7%
Debt-to-equity 182 % +87.1%
Return On Equity -115 % -2.07%
Return On Assets -40.6 % +28.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 184M shares -2.97%
Common Stock, Shares, Outstanding 184M shares -2.97%
Entity Public Float 109M USD -84.5%
Common Stock, Value, Issued 19K USD 0%
Weighted Average Number of Shares Outstanding, Basic 195M shares +3.11%
Weighted Average Number of Shares Outstanding, Diluted 195M shares +3.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 90.2M USD +1.51%
Research and Development Expense 111M USD -21.5%
General and Administrative Expense 76.5M USD -11.1%
Costs and Expenses 255M USD -47.3%
Operating Income (Loss) -164M USD +58.3%
Nonoperating Income (Expense) -11.6M USD +33.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -176M USD +57.3%
Income Tax Expense (Benefit) -172K USD -106%
Net Income (Loss) Attributable to Parent -176M USD +57.6%
Earnings Per Share, Basic -0.91 USD/shares +58.8%
Earnings Per Share, Diluted -0.91 USD/shares +58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.6M USD -36.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.62M USD +20.8%
Inventory, Net 16.2M USD -19.8%
Other Assets, Current 10.7M USD -2.42%
Assets, Current 320M USD -34.9%
Property, Plant and Equipment, Net 17.5M USD -35.5%
Operating Lease, Right-of-Use Asset 17.3M USD -59.1%
Goodwill 0 USD -100%
Other Assets, Noncurrent 4.66M USD +231%
Assets 396M USD -29.5%
Accounts Payable, Current 8.76M USD +137%
Employee-related Liabilities, Current 7.38M USD -50.4%
Accrued Liabilities, Current 24.3M USD -35.1%
Liabilities, Current 52.4M USD -12.5%
Operating Lease, Liability, Noncurrent 94.7M USD -13.4%
Other Liabilities, Noncurrent 4.33M USD -33.1%
Liabilities 269M USD -16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -403K USD +92.9%
Retained Earnings (Accumulated Deficit) -3.51B USD -5.27%
Stockholders' Equity Attributable to Parent 127M USD -47.4%
Liabilities and Equity 396M USD -29.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -47.9M USD +7.76%
Net Cash Provided by (Used in) Financing Activities 42M USD
Net Cash Provided by (Used in) Investing Activities 19.3M USD -52.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 192M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.6M USD -36.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 855M USD +4.69%
Deferred Tax Assets, Gross 859M USD +3.7%
Operating Lease, Liability 118M USD -10.4%
Payments to Acquire Property, Plant, and Equipment 157K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -171M USD +58.8%
Lessee, Operating Lease, Liability, to be Paid 140M USD -13%
Operating Lease, Liability, Current 19.4M USD +3.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.3M USD +3.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.8M USD +3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.7M USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23M USD +3.16%
Deferred Tax Assets, Operating Loss Carryforwards 575M USD +5.36%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) -60K USD -112%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 126M USD +47.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.7M USD +3.15%
Operating Lease, Payments 21M USD +4.48%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -43K USD +92.9%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 7M USD -42.6%
Deferred Tax Assets, Net of Valuation Allowance 4.09M USD -65.3%
Share-based Payment Arrangement, Expense 29.4M USD -36.7%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%